{
    "code": "60000980",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60000980",
    "time": "2021-06-11 03:20:56",
    "許可證字號": "衛部菌疫輸字第000980號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/09\/01",
    "發證日期": "104\/09\/01",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000098000",
    "中文品名": "類克凍晶注射劑",
    "英文品名": "Remicade powder for concentrate for solution for infusion",
    "適應症": "1. 克隆氏症：適用於對傳統治療無效之成人中度至重度活動性克隆氏症，可減輕症狀與徵兆及誘導與維持臨床緩解；適用於對傳統治療(包含抗生素、引流與免疫抑制劑)反應不佳之成人活動性瘻管性克隆氏症。\r\n2. 小兒克隆氏症：適用於對皮質類固醇及免疫調節劑(immunomodulators)反應不佳之小兒(6-17歲)中度至重度活動性克隆氏症，可減輕症狀與徵兆及誘導與維持臨床緩解。\r\n3. 潰瘍性結腸炎：適用於對皮質類固醇和6-mercaptopurine (6-MP)或azathioprine (AZA)等傳統治療無效、無法耐受或有醫療禁忌之中度至重度活動性潰瘍性結腸炎成人病人。\r\n4. 小兒潰瘍性結腸炎：適用於對皮質類固醇和6-mercaptopurine (6-MP)或azathioprine (AZA)等傳統治療無效、無法耐受或有醫療禁忌之中度至重度活動性潰瘍性結腸炎小兒(6-17歲)病人。\r\n5. 類風濕性關節炎：與methotrexate併用，減緩中度到重度活動性疾病病人的徵兆及症狀，抑制結構性損傷的惡化，經HAQ-DI量表評估，可改善日常生活功能。\r\n6. 僵直性脊椎炎：減緩活動性疾病病人的徵兆及症狀。",
    "劑型": "243凍晶注射劑",
    "包裝": "100毫克玻璃小瓶裝 100瓶以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "109\/09\/01",
    "主成分略述": "Infliximab",
    "限制項目": "02輸　入 1D須執行風險管理計畫 51免除銜接性臨床試驗",
    "申請商名稱": "6201010313  台田藥品股份有限公司",
    "申請商地址": "臺北市南港區市民大道七段8號14樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "FCH0015000  CILAG AG.",
            "製造廠廠址": "HOCHSTRASSE 201 CH-8200 SCHAFFHAUSEN SWITZERLAND",
            "製造廠公司地址": "VIA M. BUONARROTI 23 20093 COLOGNO MONZESE,ITALY",
            "製造廠國別": "SWITZERLAND",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FNL0059000  JANSSEN BIOLOGICS B.V.",
            "製造廠廠址": "EINSTEINWEG 101, 2333 CB LEIDEN, THE NETHERLANDS",
            "製造廠公司地址": "EINSTEINWEG 92, 2333 CD LEIDEN, THE NETHERLANDS",
            "製造廠國別": "NETHERLANDS",
            "製程": "主成分(drug substance)製造廠"
        },
        {
            "製造廠名稱": "FUS0789100  JANSSEN BIOTECH INC.",
            "製造廠廠址": "200 GREAT VALLEY PARKWAY MALVERN, PENNSYLVANIA 19355-1307, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "主成分製造及許可證持有者"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200081100",
            "成分名稱": "Infliximab",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Remicade_vial picture-104-12-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000980&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "20210515_Remicade_TW PI revision_CDE_Clean ver(Chinese)-110-05-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000980&Seq=005&Type=9"
        },
        {
            "title": "37807C_3-108-08-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000980&Seq=007&Type=8"
        },
        {
            "title": "類克凍晶注射劑-標籤-107-09-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000980&Seq=005&Type=8"
        },
        {
            "title": "類克凍晶注射劑-外盒-107-09-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000980&Seq=004&Type=8"
        }
    ]
}